Dr. Ole Isacson is Professor of Neurology (Neuroscience) at Harvard Medical School and founding Director of the Neuroregeneration Research Institute and the Neuroregeneration Laboratory at McLean Hospital, an NIH Udall Parkinson's Disease Research Center of Excellence Awardee and leader of the extramural NIH iPS cell consortium for Parkinson’s disease. Dr. Isacson’s work on Parkinson’s disease is focused on new treatment paradigms based on discoveries of critical mechanisms, biomarkers and treatments of neuronal vulnerability prior the onset of disease, or unique restorative treatments using human dopamine neurons derived from patient stem cells after symptoms have developed.
Prof. Isacson is also a member of the Scientific Advisory Board of the Harvard NeuroDiscovery Center and Principal Faculty of the Harvard Stem Cell Institute. He is a member of the Executive Scientific Advisory Board of the Michael J. Fox Foundation. Prof. Isacson is a member of FDA’s CBER Advisory Committee on Cellular, Tissue and Gene Therapy. He is the Editor-in-Chief of the journal, Molecular and Cellular Neuroscience. Prof. Isacson was elected fellow to the American Association for the Advancement of Science (AAAS) in 2013. He is author or co-author of over 300 scientific research articles and 3 books in his field.